HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Topical metronidazole combination therapy in the clinical management of rosacea.

Abstract
Metronidazole was the first topical agent approved by the U.S. Food and Drug Administration for the treatment of rosacea. Several controlled studies have confirmed the efficacy and safety of topical metronidazole 0.75% gel, lotion and cream and 1% cream for rosacea. At present, little data exists regarding the use of combination topical therapy in rosacea management, although anecdotal evidence and preliminary studies suggest at least some additive benefit when topical metronidazole is used in combination with sulfacetamide 10% /sulfur 5%. In this paper, the results of observational experience evaluating topical metronidazole 0.75% gel used in combination with other topical rosacea therapies and/or subantimicrobial dose doxycycline are reported.
AuthorsJames Q Del Rosso, Joseph Bikowski
JournalJournal of drugs in dermatology : JDD (J Drugs Dermatol) 2005 Jul-Aug Vol. 4 Issue 4 Pg. 473-80 ISSN: 1545-9616 [Print] United States
PMID16004021 (Publication Type: Journal Article, Review)
Chemical References
  • Metronidazole
  • Sulfacetamide
  • Doxycycline
Topics
  • Administration, Topical
  • Adult
  • Aged
  • Disease Management
  • Doxycycline (administration & dosage)
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Metronidazole (administration & dosage)
  • Middle Aged
  • Rosacea (drug therapy, pathology)
  • Sulfacetamide (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: